News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,335 Results
Type
Article (88747)
Company Profile (816)
Press Release (793751)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233575)
Career Advice (4162)
Deals (39981)
Drug Delivery (177)
Drug Development (91689)
Employer Resources (207)
FDA (18552)
Job Trends (17484)
News (398699)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
Adcomms (40)
Allergies (193)
Alliances (56989)
ALS (234)
Alzheimer's disease (1962)
Antibody-drug conjugate (ADC) (548)
Approvals (18882)
Artificial intelligence (858)
Autoimmune disease (351)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6519)
Cardiovascular disease (549)
Career advice (3597)
Career pathing (52)
CAR-T (381)
CDC (76)
Celiac Disease (3)
Cell therapy (1061)
Cervical cancer (53)
Clinical research (78914)
Collaboration (2343)
Company closure (8)
Compensation (1503)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1264)
Cystic fibrosis (167)
Data (8607)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (689)
Diagnostics (7584)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (419)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102477)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138485)
Executive appointments (1186)
FDA (22586)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1916)
Gene editing (269)
Generative AI (89)
Gene therapy (845)
GLP-1 (1277)
Government (5556)
Grass and pollen (8)
Guidances (419)
Healthcare (21248)
HIV (92)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (351)
Immuno-oncology (114)
Indications (202)
Infectious disease (3433)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (314)
Interviews (821)
IPO (17997)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (868)
Lymphoma (460)
Machine learning (66)
Management (66)
Manufacturing (1207)
MASH (223)
Medical device (15266)
Medtech (15416)
Mergers & acquisitions (23267)
Metabolic disorders (1798)
mRNA (263)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (500)
Neuropsychiatric disorders (126)
Neuroscience (3691)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5142)
Now hiring (80)
Obesity (860)
Opinion (373)
Ovarian cancer (242)
Pain (282)
Pancreatic cancer (343)
Parkinson's disease (412)
Partnered (39)
Patents (645)
Patient recruitment (736)
Peanut (70)
People (67938)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24388)
Phase 2 (34277)
Phase 3 (25779)
Pipeline (9610)
Policy (396)
Postmarket research (3559)
Preclinical (10966)
Press Release (72)
Prostate cancer (342)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1246)
Real estate (7462)
Recruiting (81)
Regulatory (30333)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (195)
Series A (324)
Series B (232)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1300)
Venture capital (131)
Weight loss (588)
Women's health (139)
Worklife (24)
Date
Today (95)
Last 7 days (755)
Last 30 days (3157)
Last 365 days (33144)
2026 (15697)
2025 (33219)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52259)
Australia (9187)
California (14281)
Canada (3988)
China (1552)
Colorado (612)
Connecticut (636)
Delaware (440)
Europe (120505)
Florida (2116)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1236)
India (102)
Indiana (661)
Iowa (25)
Japan (584)
Kansas (143)
Kentucky (56)
Louisiana (61)
Maine (89)
Maryland (1735)
Massachusetts (10430)
Michigan (421)
Minnesota (795)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3786)
New Mexico (35)
New York (3753)
North Carolina (1926)
North Dakota (11)
Northern California (7090)
Ohio (443)
Oklahoma (26)
Oregon (55)
Pennsylvania (2819)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5604)
Tennessee (225)
Texas (2323)
United States (51083)
Utah (425)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1176)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,335 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Merck continues New Jersey cuts, laying off 88 in Rahway
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
June 8, 2026
·
57 min read
·
BioSpace Editorial Staff
Obesity
ADA: Lilly sets ‘new record in Weight Loss Olympics’ with next-gen asset
Over two years of treatment, Eli Lilly’s triple-G drug cut body weight by more than 30% in certain patients with obesity, cementing the pharma’s position as the frontrunner in the metabolic space.
June 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
June 8, 2026
·
6 min read
Press Releases
Alligator Bioscience Comments on Henlius Update on Global Phase 3 Trial with HLX22
June 8, 2026
·
2 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
·
6 min read
Press Releases
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
June 8, 2026
·
4 min read
Press Releases
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 8, 2026
·
4 min read
Press Releases
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
·
12 min read
Press Releases
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
June 8, 2026
·
7 min read
Press Releases
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
June 8, 2026
·
10 min read
1 of 88,334
Next
